Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study on Palatability-Improving Intake Methods for MOVICOL Combination Powder LD
jRCT1041240066Active, not recruiting
- Sponsor
- Hamamatsu University of Medicine
- Start
- Jul 2024
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of polyethylene glycol in constipation, sponsored by Hamamatsu University of Medicine. Primary endpoint: Overall palatability. Started Jul 2024; status: active, not recruiting.
02
Drugs
polyethylene glycol
03
Conditions
constipation
Beyond the preview
Go deeper on jRCT1041240066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041240066.